You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
McKinsey

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

Patent: 8,505,315

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,505,315
Title:Enhanced integrated operation blender based sterile medical ice slurry production device
Abstract: A method and device are provided for the preparation of sterile medical ice slurry, for example having ice loadings of greater than approximately 50%. An integrated-operation ice slurry blender-based production and delivery system methods for monitoring cooling capacity of the produced and delivered slurry. All individual medical ice slurry production and delivery steps are integrated into one tightly coupled precisely sequenced and timed system. The novel procedure and equipment is simple to use and makes sterile slurry, which is ready to deliver to patients, for example, in less than 2 minutes after adding predetermined thermally preconditioned ingredient modules to a blender.
Inventor(s): Kasza; Kenneth E. (Palos Park, IL), Shareef; Farah J. (Lombard, IL), Fisher; Brandon L. (Plainfield, IL)
Assignee: UChicago Argonne, LLC (Chicago, IL)
Application Number:12/367,362
Patent Claims:see list of patent claims

Details for Patent 8,505,315

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial UChicago Argonne, LLC (Chicago, IL) 2028-04-15 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial UChicago Argonne, LLC (Chicago, IL) 2028-04-15 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Colorcon
McKesson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.